Amgen’s Russell Abberley, Vice President and General Manager UK and Ireland, is stepping up as Acting President of The Association of the British Pharmaceutical Industry (ABPI). We congratulate Russell on this achievement and his dedication to the life science industry. 🔬
Amgen
Biotechnology Research
Thousand Oaks, CA 1,248,298 followers
#WeareBiotech
Über uns
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.
- Website
-
http://www.amgen.com
External link for Amgen
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 10.001+ Mitarbeiter
- Hauptsitz
- Thousand Oaks, CA
- Typ
- Öffentliches Unternehmen
- Gegründet
- 1980
- Spezialitäten
- Biologics, Human therapeutics, and Development of novel products
Standorte
Employees at Amgen
Aktualisierungen
-
Amgen’s lead scientist focused on MariTide, Murielle Veniant, PhD., will be speaking about anti-obesity therapeutic strategies and the promise of GIP and GIPR antagonism at the European Association for the Study of Diabetes e.V. (EASD) Annual Meeting. 🎧 📘 Hear what led Murielle to find her passion for #obesity research in the latest Amgen story: https://amgen.ly/3ASk0zJ #EASD2024
-
With great admiration for their resilience and dedication to the #RareDisease community, Amgen is announcing the 75 recipients of 2024 #RAREis Global Advocate Grant. 🔗 https://lnkd.in/gtcHgZpA Driven by a tireless devotion to advance, educate and address the needs of all those impacted by rare diseases, these organizations continue to reinforce that the future of rare care is bright and full of hope. We’re proud to support new recipients, as well as past recipients like The E.WE Foundation, Usher Syndrome Ireland and Instituto Atlas Biosocial to enable continued programming. 🎉 Congratulations to all organizations for their contributions!
-
Fact: Knowing your LDL (“bad”) cholesterol levels is a critical step in understanding your risk for heart attack and stroke. This National Cholesterol Education Month, join Amgen’s #CheckLDL testing challenge to ensure you’re regularly checking your LDL-C levels. Listen to Ian Thompson discuss the urgency and importance of getting tested. 🔗 For more information on how to get a free LDL-C test, especially if you live with heart disease, visit https://amgen.ly/checkldl
Join Amgen's Testing Challenge
-
Cardiovascular disease remains a major global health challenge, but there’s no one-size-fits-all solution. That’s why Amgen is supporting a program with the Global Alliance For Patient Access, focused on co-creating localized strategies tailored to the unique needs of each country. These initiatives are empowering patients and communities in Australia, Canada, China and South Africa to take charge of their heart health. 🔗 Discover how these efforts are making a real difference in cardiovascular care: https://amgen.ly/3XmIKJh
-
It’s been one year since Amgen established its bold ambition to cut the number of heart attacks and strokes in half by 2030. Since then, our work with leading researchers, healthcare professionals, and community organizations has driven innovation, produced results, and continues to help transform cardiovascular care. As we head to European Society of Cardiology’s #ESCCongress in London, we remain focused on this goal and its potential to improve care for patients. 🔗 Learn more about our progress: https://amgen.ly/3MtBHs1
-
Competitive health benefits, work/life balance perks, and annual two-week company-wide shutdowns—support at Amgen is simply one-of-a-kind. Learn more about how our benefits help bring out your best for your career and patients worldwide: https://bit.ly/4e2wEub
-
Thank you, Disability:IN, for recognizing Amgen as a Best Place to Work for Disability Inclusion. This award and top score of 100 were made possible through our team members’ commitment to leading disability inclusion practices, as well as the work accomplished by our ABLE Employee Resource Group. Learn more about Life at Amgen: https://lnkd.in/gcUH7vAg